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Labour’s “Black report” moment?
Editor—The release of the government’s
latest report on health inequalities on 11
August was curious.1 2 Reminiscent of the
covert release of the Black report on August
bank holiday in 1980, the report appeared
when the minister for public health was on
holiday and her deputy unavailable.
Personal trainers
In July 2003 the government stated that
there would be an annual report from the
Department of Health on health inequality
indicators related to the health inequality
targets. Nothing appeared for more than
two years, although the data that were even-
tually released had been available for some
time,3 and when they did appear it was, con-
veniently, after the election. Even stranger,
the press release for the latest report
deflected attention from the key finding of
widening inequalities in life expectancy and
infant mortality by headlining the 12 “early
adopter sites” with their “health trainers.”4
The minister said, “Many people have
difficulty in changing to a healthier way of
life . . . Health trainers are one of the
many initiatives in the white paper which
will help narrow this gap by supporting
people to make healthier choices in their
daily lives.”4
To Labour traditionalists, opposed to
victim blaming approaches to health pro-
motion, this may have triggered memories
of Conservative minister Edwina Currie
admonishing the poor to buy cheap but
healthy food. To New Labour, however, it
may be grist to the mill.
Shifting goal posts
The circumstances of the release of the
report should not be allowed to detract
from its main message—that health
inequalities, as measured by both spatial
differences in life expectancy and socioeco-
nomic differences in infant mortality, have
widened. The latest data for life expectancy
(2001-3) show that the gap between
England as a whole and the fifth of local
authorities with the lowest life expectancy
has increased, by 2% for males and by 5%
for females.
The assessment of trends in health
inequalities has not been helped by targets
that have had their spatial and social units
altered, start dates shifted, and measures
changed repeatedly in their short lives.
The life expectancy target first mentioned
health authorities (which were soon
abolished), then the fifth of local authorities
with the lowest life expectancy, and now a
“spearhead” group. Curiously, the 12
early adopter sites with their health trainers
overlap with (but are not exclusively
drawn from) the spearhead group. The
spearhead group will (for now) be used to
measure progress towards the life expect-
ancy target.
The infant mortality target has likewise
been reformulated, as the official measure of
social class has changed. Moreover, neither
of the targets is a true health inequalities tar-
get as they compare the worst off groups
with the average for the population as a
whole rather than considering the entire
distribution.3 Indeed, the rapid moving of
goal posts seems to have confused the draft-
ers of this report, with 2001, 2002, and 2003
all being described as start dates. In fact, New
Labour’s health inequality targets were
announced in July 2000 in the NHS plan
and formalised in February 2001.5 6
Widening inequalities
In opposition Labour consistently prom-
ised to implement the recommendations of
the Black report and was incensed by the
attempt to cover it up 25 years ago, as
well as by the similar attempt to suppress
the impact of the follow-up report in
1987.7
The hushed up release of this report
raises fears that the bold statements and
unprecedented promises of Labour’s first
years in power—for example, the pledge to
eradicate child poverty within a
generation—have now been wholly over-
taken by the individualistic rhetoric of
behavioural prevention and “choosing
health” and its three principles of
“informed choice, personalisation, and
working together.” The linking of the
adverse trends in health inequalities with
the introduction of health trainers is a
prime example of this.
Although the proportion of children liv-
ing in low income households is a national
indicator, the report nowhere mentions
measuring, let alone directly tackling, the
static or widening inequalities in income and
wealth that New Labour has presided over,
widening housing wealth inequalities being
a prime example.8 Perhaps rather than
focusing on changing the health choices of
millions of people the government should
think more about a healthier way to govern
and at last choose to use the tax and benefit
systems to kerb growing social inequalities
in income and wealth.
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Making prison health care
more efficient
The cost may be higher than the price
Editor—By focusing on the price of prison
health care in the editorial by Awofeso,1 the
BMJ has done a major disservice to communi-
ties that pay for poor (in both meanings of the
word) prison health care in non-fiscal ways.
Cost and price are not interchangeable
concepts. The prison is a particular environ-
ment that gives access to health care for
those who are often excluded in other
settings: the price of the care should be set
against the cost of its absence.
Degradation of the wider public health—
for example, through culturing bloodborne
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diseases in prisons with inadequate services
to prevent needle sharing—and degradation
of public order by the reoffending that
follows inadequately addressed forensic
mental health problems are costs borne by
populations but hardly noticed by criminal
justice ministers.
While locking fewer people upmay keep
us safer from disease, it carries political risks
that are difficult to take in democracies.
More mechanisation would inevitably
reduce the good interpersonal work done by
many prison officers: it carries the inevitable
risk of increasing the social and health costs
of imprisonment.
Governments reward custodial agencies’
custodial objectives (not escaping) much
better than their care objectives (not
reoffending or becoming ill). Until the costs
of incarceration as well as its price are meas-
ured, the public health will remain threat-
ened by the inadequate resources directed
to health care in prisons.
Andrew J Ashworth general practitioner principal
Davidson’s Mains Medical Centre, Edinburgh
EH4 5BP
andrew.ashworth@lothian.scot.nhs.uk
Competing interests: AJA is a former prison
doctor and past chairman of the BMA’s civil
service committee.
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Europe’s initiative and progress should
be noted
Editor—While it is very useful to be
reminded about the need for cost efficiency
in prison health services, the importance of
effective prison health services to public
health in general should also be empha-
sised. Awofeso did not have the space to
underline the public health importance of
good prison health in his editorial on
making prison health more efficient.1 His
concentration on experience in the United
States, the United Kingdom, and Australia
also pays insufficient attention to initiatives
in Europe.
For example, the World Health Organi-
zation’s Health in Prisons Project, launched
in 1995, now has 10 years’ experience in
promoting health in prisons and custodial
settings.2 Thirty two countries of Europe are
committed to the project, through their
prison health policies, showing a willingness
to develop best practice guidance on
preventing disease and promoting health in
prisons on the basis of evidence and experi-
ence.3 The project will hold its 10th annual
meeting in London next month. The
meeting will review progress so far, the
impact of its several consensus papers and
policy documents, and the priorities for
future action.
All countries are facing the same impor-
tant public health issues, to which good
prison health can make a worthwhile contri-
bution. It is time for a global initiative, so that
all regions of the world can learn from each
other in this challenging area of public
health.
Alex Gatherer former honorary visiting fellow
Green College, Oxford OX2 6HG
alexgatherer@aol.com
Competing interests: AG is a temporary adviser
to the WHO Regional Office for Europe’s
Health in Prisons Project.
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Preventing severe infection
after splenectomy
What about old splenectomies?
Editor—Newland et al point out that
patients who have had a splenectomy should
know the risks, be immunised, and take pro-
phylactic antibiotics.1 But what should
happen for patients who were operated on a
long time ago (more than 20 years) who
have never had any vaccines and are not
having antibiotic treatment? No guidelines
exist for such patients.
Stephen Sciberras senior house officer
St Luke’s Hospital, Malta
stefe@di-ve.com
Competing interests: None declared.
1 Newland A, Provan D, Myint S. Preventing severe infection
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Risk of malaria and meningitis increases
with asplenia
Editor—The editorial by Newland et al on
preventing severe infection after splenec-
tomy deals with the risks of malarial
infection and meningitis in asplenic travel-
lers rather cursorily.1
Asplenia, from whatever cause, is not
uncommon. Worldwide travel to malarial
areas is probably increasing. Increased risks
of Plasmodium falciparum malaria in asplenic
people, although difficult to quantify, are
widely recognised. Fatal outcomes, anecdo-
tally, are increased: I have heard of three
people who acquired malaria in west Africa
and died. Incidence of meningitis in
sub-Saharan Africa, India, and Nepal poses
substantial potential hazards.
Asplenic travellers should be advised to
avoid travel to high risk malarial areas. People
who travel should scrupulously adhere to
measures to avoid bites and take appropriate
antimalarial prophylaxis. Immediate referral
for medical advice is essential should a fever
develop. People travelling to areas with a high
incidence of meningitis must be immunised
with meningococcal ACWY vaccine (quadri-
valent polysaccharide vaccine that provides a
level of protection against meningococcal
disease due to groups A, C,W135, and Y).
Harald M Lipman medical adviser, travel health clinic
Number One Health Group, London W1G 9QD
haraldlipman@aol.com
Competing interests: HML is associated with a
travel health screening clinic.
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Authors’ reply
Editor—Sciberras asks an important ques-
tion, as many asplenic patients had surgery
at a time when the risks of postoperative
infection were even less appreciated than at
present. Although most infections do occur
in the first two years after surgery, most
studies will have patients who have had
infections as long ago as 20 years.
At this stage undertaking a course of
immunisations is worth while, but whether
prophylactic antibiotics are necessary is
arguable. In theory they should be given,
particularly if there is any evidence of
immunosuppression—for example, if the
patient is taking steroids—but many patients
would find it difficult to understand the
need, and compliance is likely to be low. Our
policy would be to explain the low level of
risk and let the patient have a supply of anti-
biotics to take if there is evidence of
developing infection.
For reasons of space we were not able to
give the increased risk of malaria and
meningitis the importance it deserves. At a
time of increasing travel to far flung and
exotic places, the risks should be known to
everyone giving travel advice and to the
patients themselves. We are all aware of such
cases and emphasise the risks to patients
who have had a splenectomy.
Adrian Newland professor
a.c.newland@qmul.ac.uk
Drew Provan senior lecturer
Department of Haematology, St Bartholomew’s
and the Royal London School of Medicine and
Dentistry, London El IBB
Steven Myint editor in chief, Journal of Infection
The Brae, Dunmow, Essex CM6 1HU
Competing interests: None declared.
Embracing Cicely Saunders’s
concept of total pain
Editor—Dame Cicely Saunders defined the
concept of total pain as the suffering that
encompasses all of a person’s physical,
psychological, social, spiritual, and practical
struggles.1 Coyle also wrote that a diagnosis
of a life threatening illness jars open a door
of awareness,2 the same door that, for most
of our lives, comfortably allows us to keep
thoughts about death in the background.
For many people the opening of this
door precipitates a crisis and an acute
encounter with great total pain. All of this
occurs in the context of a modern society
that is ill equipped to handle news of possi-
ble death.3 Consequently, after diagnosis of a
life threatening or life limiting illness, a
patient’s close family and friends may deny
that their loved one is dying or might die
from his or her illness. Additionally, as death
is now routinely hidden from social view and
medicalised,4 5 this medicalisation, which
professionalises the rituals of caring for
Letters
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those who are seriously ill or dying, can
result in a situation in which only the physi-
cal symptoms are given priority.3
Therefore, after the diagnosis, the
patient may be acutely isolated, with total
pain at risk of being left untended. Certain
aspects of palliative care, such as day care,
have much to offer from the point of
diagnosis. We urge health professionals,
patients, and their families to access or refer
to the help that is available from palliative
care services—in particular, the day units
with well developed support services. Such
help must be offered irrespective of whether
the diagnosis pronounces the end of life or
may yet still offer hope of the resumption of
more life, for once the door of mortality is
opened, the good life will never be quite the
same again.
Chi-Keong Ong head of research and service evaluation
p.ong@warwick.ac.uk
Duncan Forbes chief executive
Shakespeare Hospice, Shottery,
Stratford-upon-Avon, Warwickshire CV37 9UL
Competing interests: None declared.
C-KO is also associate research fellow at the Centre
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Cardiac impairment or heart
failure?
What about “cardiovascular insufficiency
syndrome”?
Editor—As a non-clinical researcher cur-
rently engaged in a qualitative study of emo-
tions and coping in chronic heart failure, I
welcome Lehman et al’s editorial debating
the label “heart failure.”1
At a recent meeting with a group of gen-
eral practitioners the issues of communica-
tion between doctor and patient and the use
of the term “heart failure” were the
dominant feature. Not only does failure, for
patients, mean the end of hope but it also
carries pejorative connotations of culpabil-
ity, particularly against the prevailing public
health and health promotion background,
which emphasises behaviour and lifestyle in
the aetiology of heart disease.
The complexity of heart failure can be
viewed in many ways, depending on training
and professional experience. Physiologists
identify one common component across
varieties of heart failure as the inability of
the cardiovascular system, as a whole, to
maintain an adequate pressure gradient in
the circulation. Obviously, many of the
causes of this inability lie with the structure
and function of the heart itself, but that is
not the whole story.
Blame should be deflected away from
the heart by using “cardiovascular” as the
first element of a revised nomenclature.
“Insufficiency” is a suitable generic term for
the range of deficits in function of the
system currently covered by the label heart
failure. The variety and complexity of
expressions of this condition indicate that it
should be described as a syndrome.
“Cardiovascular insufficiency syn-
drome” is a fairly accurate description,
reasonably comprehensive, and, impor-
tantly, can conveniently be abbreviated to a
simple acronym, CIS.
J David Mitchell researcher in health and medical
sociology
Division of Primary Care, University of Liverpool,
Liverpool L69 3GB
jdavidm@liverpool.ac.uk
Competing interests: None declared.
1 Lehman R, Doust J, Glasziou P. Cardiac impairment or
heart failure? BMJ 2005;331:415-6. (20-27 August.)
“Impairment” is no less alarming or
confusing than “failure”
Editor—Lehman et al consider the term
“heart failure” to be imprecise and confus-
ing, preferring “cardiac impairment.”1
However, the term “cardiac impairment”
is as vague and blurred. It is not more
descriptive or less confusing. Impairment
also covers a wide spectrum or continuum.
Paradoxically, it may not reflect the serious-
ness of the diagnosis, especially in late stages
of heart failure when the prognosis may be
more serious than that for many malignan-
cies.
Whatever term is used, doctors can
avoid confusion by explaining that failure,
like many things in life and medicine, is a
spectrum, and it does not mean the end.
Also patients should be given time and
encouragement to ask questions and air
fears and concerns.
Atef Michael specialist registrar
Queen’s Hospital, Burton on Trent DE15 0AR
a.michael2@ukonline.co.uk
Competing interests: None declared.
1 Lehman R, Doust J, Glasziou P. Cardiac impairment or
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Changing the name has knock-on effects
Editor—Lehman et al suggest calling
“heart failure” “cardiac impairment.”1 As a
clinical coder, I bring to your attention that
“heart failure” is coded to the ICD-10 (inter-
national classification of diseases, 10th
revision) code I50.9; the description of this
code includes “heart failure, biventricular
failure, and cardiac, heart or myocardial
failure, not otherwise stated.” However, a
diagnosis of “heart impairment” with no fur-
ther qualifying description sends coders to
the code I51.9; the description of this code is
“heart disease, unspecified.”
If a change of description of the
condition is decided on by clinicians, please
would they consider informing their clinical
coding departments of the change? If
coding departments were not informed, the
codes applied to the condition might well
alter with the change of name, even though
the condition itself stayed the same.
Catie Gilbert clinical coder
Clinical Coding Department, West Suffolk Hospitals
NHS Trust, Bury St Edmunds, Suffolk IP33 2QZ
catie.gilbert@wsh.nhs.uk
Competing interests: None declared.
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What do patients really think?
Editor—The editorial by Lehman et al
debates renaming heart failure.1 We agree
from our research that many patients do not
understand what the term heart failure
means.We believe that it would be a shame to
substitute the word “heart” with “cardiac”: this
may cause more confusion as many patients
may not know what the word cardiac means.
We interviewed 40 patients from around
the country at different stages of heart
failure, and many of them discussed their
confusion about the meaning of heart
failure—several said that the word failure
was unhelpful (these interviews can be seen
on www.dipex.org/heartfailure).
Before officially renaming, it might be
helpful to have a wider debate about this and
ask patients for their opinions.
Kate H Field senior qualitative researcher
kate.field@dphpc.ox.ac.uk
Ann McPherson part time lecturer
Department of Primary Care, University of Oxford,
Oxford OX3 7LF
Competing interests: Both authors have done
research on heart failure in 2003 for DIPEx, Uni-
versity of Oxford.
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heart failure? BMJ 2005;331:415-6. (20-27 August.)
Time for total political correctness?
Editor—Lehman et al point out that the
term “cardiac failure” is less than helpful. It
confuses doctors and it demoralises
patients.1 Cardiac impairment may be, as
they suggest, “kinder, and more accurate.”
It is still not quite in tune with the politi-
cally correct culture of the past couple of
decades.2 We would suggest a more appro-
priate, and current, term, “cardiac deferred
success.” It really implies no blame to
anyone: much better.
Bernard A Foëx consultant in emergency medicine
and critical care
bernard.foex@cmmc.nhs.uk
Simon Carley locum consultant in emergency medicine
Department of Emergency Medicine, Manchester
Royal Infirmary, Manchester M13 9WL
Competing interests: None declared.
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2 Michel T. The guide to politically correct cardiology. J Irre-
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